ACG has always been at the forefront of technology for the pharmaceutical industry. Its aim is simple: to lead the way for higher standards, innovation and excellence in the field.

ACG is proud to present the DESTINY 8100, a high speed, fully automated, double rotary tablet press, designed to meet the most challenging tabletting production requirements.

The DESTINY 8100 brings high speed, fully automated operations for high volume products, providing cost-effective solutions to the pharmaceutical industry. With 21CFR part 11 and audit trail compliance, it meets the most stringent regulatory compliance norms.

The DESTINY 8100 is a double sided tablet press with cGMP features, higher accessability to the compression zone, virtually tool free changeover and the capability for bilayer tablets using retrofitable bilayer kit.

Special Features

• Robust European machine design for strength and stability
• Improved product quality due to rotary versatile feeder design
• Exit chute with separate production, sampling and rejection gates
• Automatic Weight Control based on compression force measurement
• Higher output up to 1 million tablets/hour
• Enhanced EHS standards Stand alone, climatically controlled electrical cabinet